Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : TC-G 1008
CAS No.: 1621175-65-2
Catalog No.: PC-60593Not For Human Use, Lab Use Only.
TC-G 1008 (TC-G-1008, GPR39-C3) is a potent, selective, orally bioavailable GPR39 agonist with EC50 of 0.4 and 0.8 nM for rat and human GPR39, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $98 | In stock | |
| 10 mg | $158 | In stock | |
| 25 mg | $278 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TC-G 1008 (TC-G-1008, GPR39-C3) is a potent, selective, orally bioavailable GPR39 agonist with EC50 of 0.4 and 0.8 nM for rat and human GPR39, respectively.
TC-G 1008 displays high selectivity over a broad panel of kinases (IC50> 10 uM), and ghrelin and neurotensin-1 receptors (IC50>30 uM).
TC-G 1008 robustly induces acute GLP-1 levels and shows the potential oral treatment of type 2 diabetes.
| M.Wt | 418.9 | |
| Formula | C18H19ClN6O2S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
100 mM in DMSO |
|
| Chemical Name/SMILES |
N-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide |
|
1. Młyniec K, et al. J Affect Disord. 2016 Sep 1;201:179-84.
2. Sato S, et al. Mol Pharmacol. 2016 Dec;90(6):726-737.
3. Shimizu Y, et al. Biochem Pharmacol. 2017 Sep 15;140:105-114.
4. Peukert S, et al. ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
